Form D · Biotechnology

PERSOWN, Inc.

Jacksonville, FL · CIK 0001826054

Offering snapshot reported Jun 23, 2023 · SEC filing

Reported sold
$25K
Offering amount: $1M
Investors reported
2
Form D · investor count
Minimum accepted
$12.5K
Reported outside-investor minimum
First sale
Jun 6, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 23, 2023Initial$25,000No comparison2SEC filing
Sep 28, 2022Initial$343,500No comparison11SEC filing
Dec 10, 2021Initial$780,000No comparison10SEC filing
Apr 19, 2021Initial$996,000No comparison11SEC filing
Apr 19, 2021Amendment$707,250$564,750vs Oct 26, 202020SEC filing
Oct 26, 2020Initial$142,500No comparison10SEC filing

Offering details

Securities
Equity, Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-485071

Source: Form D, filed Jun 23, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Craig Castor Director
Eric Doherty Executive
David Greenspan Director
David Greenspan, Ph.D. Director, Executive
Jamie Grooms Director
Kevin Hayes Director
William D Meadow Director
William D. Meadows Director, Executive
Richard S Still Director, Executive
Karen Teitelbaum Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
9143 Philips Hwy Suite 390
Jacksonville, FL, 32256